Here are what the editors at HealthDay consider to be the most important developments in Cosmetic Surgery for December 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Low-Priced Generic Drugs Most Likely to Have Shortages
THURSDAY, Dec. 27, 2018 (HealthDay News) — The lowest-priced generic drugs are more likely to experience shortages, according to a study published in the November issue of Value in Health.
Abstract/Full Text (subscription or payment may be required)
Targeted Muscle Reinnervation Can Reduce Phantom Limb Pain
THURSDAY, Dec. 27, 2018 (HealthDay News) — Use of primary targeted muscle reinnervation (TMR) can prevent or reduce pain in below-the-knee amputees, according to a report published online Dec. 27 in Plastic and Reconstructive Surgery.
Abstract/Full Text (subscription or payment may be required)
Initiative Can Cut Gender Gap in Medical School Faculty Salaries
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — An institutional gender equity initiative (GEI) can reduce gender-based salary gaps among medical school faculty, according to a study published online Dec. 21 in JAMA Network Open.
New AAP Guideline Available for Infantile Hemangioma Treatment
WEDNESDAY, Dec. 26, 2018 (HealthDay News) — The American Academy of Pediatrics has developed its first guideline for the management of infantile hemangiomas (IHs); the clinical practice guideline was published online Dec. 24 in Pediatrics.
Affordable Care Act Sign-Ups Higher Than Expected
THURSDAY, Dec. 20, 2018 (HealthDay News) — Despite numerous difficulties, early figures show that sign-ups for health coverage next year under the Affordable Care Act are higher than expected.
Growth in Use of Telemedicine Seen From 2005 to 2017
THURSDAY, Dec. 20, 2018 (HealthDay News) — From 2005 to 2017, there was a substantial increase in telemedicine use, although use was still uncommon in 2017, according to a research letter published online Nov. 27 in the Journal of the American Medical Association.
FDA Advisory Panels: Prescribe Naloxone With Opioid Painkillers
WEDNESDAY, Dec. 19, 2018 (HealthDay News) — The labels of prescription opioid painkillers should advise doctors to consider simultaneously prescribing the opioid overdose antidote naloxone, two U.S. Food and Drug Administration advisory panels recommend.
Exclusion of Doctors From Public Health Insurance Up 2007 to 2017
TUESDAY, Dec. 18, 2018 (HealthDay News) — From 2007 to 2017, the number of physicians excluded from Medicare and state public insurance programs increased, according to a study published online Dec. 14 in JAMA Network Open.
Persistent Discrimination ID’d Among Physician Mothers